STOCK TITAN
  1. Home
  2. News
  3. RVMD

Revolution Medicines Inc - RVMD STOCK NEWS

IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines Advances First RAS(ON) Inhibitor into Clinic, Dosing First Patient in Phase 1/1b Trial of RMC-6236
clinical trial
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines to Participate in the 43rd Annual Goldman Sachs Global Healthcare Conference
conferences
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines Reports First Quarter 2022 Financial Results and Update on Corporate Progress
earnings
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines to Report Financial Results for First Quarter 2022 After Market Close on May 9, 2022
conferences earnings
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines Announces Seven Oral Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2022
conferences
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines to Participate in Cowen 42nd Annual Health Care Conference
conferences
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines Reports Fourth Quarter and Year-End 2021 Financial Results and Update on Corporate Progress
earnings
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2021 After Market Close on February 28, 2022
conferences earnings
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines to Participate in Guggenheim Healthcare Talks 2022 Oncology Conference
conferences
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines Reports Progress Across Pipeline of Targeted Therapeutics for RAS-Addicted Cancers in Presentation at 40th Annual J.P. Morgan Healthcare Conference
Stock RVMD logo
Revolution Medicines Inc

Nasdaq:RVMD

RVMD Rankings

#1663 Ranked by Market Cap
#2552 Ranked by Stock Gains
N/A Ranked by Dividends

RVMD Stock Data

Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
US
Redwood City

About RVMD

revolution medicines discovers and develops new drugs that harness the therapeutic potential of frontier oncology targets on behalf of cancer patients. our innovative product engine draws inspiration from nature and evolution, which offer insights into cancer targets, disease mechanisms and therapeutic approaches. we pay particular attention to natural products that are inherently rich with biological function as a result of natural selection and can inform and guide our discovery and development of small molecules that can modulate these targets.